Table 1.

Participant Characteristics

Characteristic	Sample (N=19) M (SD)
Age	52.8 (9.8)
Sexual concerns [0-10]	6.4 (2.0)
	n (%)
Race/ethnicity
White/Caucasian	15 (78.9%)
Black/African American	2 (10.5%)
American Indian or Alaskan native	1 (5.3%)
Hispanic/Latina	1 (5.3%)
Education
High School or GED	3 (15.8%)
Some college	3 (15.8%)
Completed college/Graduate school	13 (68.5%)
Employment Status
Full/Part Time	13 (68.4%)
Retired	3 (15.8%)
Unemployed/on disability/other	3 (15.8%)
Menopausal Status
Perimenopausal	2 (10.5%)
Post-menopausal	13 (68.4%)
Unsure	4 (21.1%)
Disease stage (data missing on 3 participants)
Stage I	3 (15.8%)
Stage IA	4 (21.1%)
Stage IB	1 (5.3%)
Stage II	1 (5.3%)
Stage IIA	4 (21.1%)
Stage IIIA	2 (10.5%)
Stage IIIC	1 (5.3%)
Surgery
Lumpectomy	9 (47.4%)
Mastectomy with reconstruction	10 (52.6%)
Chemotherapy
Finished chemotherapy between 6 months and 1 year ago	4 (21.1%)
Finished chemotherapy between 1 and 2 years ago	6 (31.6%)
Finished chemotherapy between 2 and 5 years ago	8 (42.1%)
Radiation Therapy
Completed radiation therapy	15 (78.9%)
Hormonal Medication Use
Currently taking tamoxifen	8 (42.1%)
Currently taking an aromatase inhibitor	12 (47.4%)